SENSEX : 39,122.96 -71.53 -0.18%
NIFTY : 11,699.65 -24.45 -0.21%
DJIA : 26,727.54 8.41 +0.03%
Nasdaq : 8,005.70 -26.01 -0.32%
Hang Seng : 28,513.00 39.29 +0.14%
Nikkei 225 : 21,285.99 27.35 +0.13%
GOLD : 34,475.00 308.00 +0.90%
SILVER : 38,082.00 128.00 +0.34%
× Services Offered DP Services Registrar and Transfer Agent(RTA) Research Equity Commodities Mutual Funds IPO NRI Investor Corner Circulars Forms DP Fund Transfer Stock Market Courses Career

Sudarshan Pharma Industries Ltd

Registered Office: 301 3rd Floor Aura Biplex,SV Road Borivali(West),Mumbai-400092, Maharashtra

Tel. No: 91-22-42221111

Fax No:



Initial public issue of 34,40,000 equity shares of face value of Rs. 10 each ("Equity Shares") of Sudarshan Pharma Industries Limited ("The Company" or "The Issuer Company") for cash at a price Rs. 72 per equity share (including a share premium of Rs. 62 Per equity share) ("Issue Price") aggregating to Rs. 24.77 crores ("The Issue"), of which 1,76,000 equity shares of face value of Rs. 10 each for a cash price of Rs. 72 per equity share, aggregating to Rs. 1.27 crores will be reserved for subscription by market maker ("market maker reservation portion"). The issue less the market maker reservation portion i.e. Issue of 32,64,000 equity shares of face value of Rs. 10 each at an issue price of Rs. 72.00 per equity share aggregating to Rs. 23.50 crores (is hereinafter referred to as the "Net Issue"). The issue and the net issue will constitute 26.49%and 25.13%, respectively of the post issue Paid up equity share capital of the company. The face value of the equity shares is Rs. 10 each and the issue price of Rs. 72 i.e. 7.2 times of the face value.

Issue Money Payable On
Opens On Closes On Application Allotment
12-Jun-2019 24-Jun-2019 ₹72.00 - 0.00 ₹0.00 - 0.00
Minimum Application for shares in Nos : 1600 Further Multiples of :1600
(₹ Cr) Lead Managers to the Issue
Project Cost 25.05 First Overseas Capital Ltd
Project Financed through Current Offer 24.77 -
Post Issue Equity Share Capital 12.99 -
Issue Price 72.00 -
To set up a dedicated manufacturing facility for pharmaceutical Business
Distribution and warehousing centre's & purchase of corporate office
Additional working capital
General corporate expenses
Promoted By
Hemal V Mehta
Sachin V Mehta
Listing At
Registrar To The Issue
Karvy Fintech Pvt Ltd
Prevent unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day..........
Attention Investor